TB during early ART doubles risk of poor CD4 gains in South Africa

A TB diagnosis during the first 12 months of antiretroviral therapy (ART) independently doubled the risk that patients at a South African HIV clinic would not gain at least 50 CD4 cells/μL during the first 6 months of therapy, according to results of a retrospective cohort study.